Subtopic Deep Dive
Graphene Nanomaterials Toxicity Assessment
Research Guide
What is Graphene Nanomaterials Toxicity Assessment?
Graphene Nanomaterials Toxicity Assessment evaluates the cytotoxic, genotoxic, and biocompatibility effects of graphene-based materials on human cells and bacteria through in vitro and mechanistic studies.
This subtopic focuses on cellular uptake, membrane disruption, and oxidative stress induced by graphene oxide and graphene nanosheets. Key studies include Liao et al. (2011) assessing cytotoxicity in human erythrocytes and skin fibroblasts (1348 citations) and Tu et al. (2013) demonstrating phospholipid extraction from E. coli membranes (1462 citations). Over 10 high-citation papers from 2010-2021 address toxicity in biomedical contexts.
Why It Matters
Toxicity data from Liao et al. (2011) and Tu et al. (2013) inform safe dosage thresholds for graphene in drug delivery, as seen in Shi et al. (2016) cancer nanomedicine review (5417 citations). These assessments ensure regulatory compliance for clinical translation, preventing adverse effects in therapeutics like those in Senapati et al. (2018) controlled drug vehicles (2070 citations). Hu et al. (2010) antibacterial paper (1965 citations) highlights dual antimicrobial and cytotoxic risks.
Key Research Challenges
Dose-Dependent Cytotoxicity Mechanisms
Determining safe thresholds remains difficult due to variable graphene oxide sizes and functionalizations affecting cell viability. Liao et al. (2011) showed dose-dependent damage in erythrocytes and fibroblasts. Variability across cell types complicates standardization.
Long-Term Biocompatibility In Vivo
Most studies like Tu et al. (2013) focus on acute bacterial effects, lacking chronic animal models for genotoxicity. Translating in vitro findings to systemic exposure is challenging. Oxidative stress pathways need deeper elucidation.
Standardized Toxicity Testing Protocols
Inconsistent assays across papers hinder comparisons, as noted in Bondarenko et al. (2013) nanoparticle toxicity review (1219 citations). Graphene's 2D structure requires unique metrics beyond spherical nanoparticles. Regulatory gaps persist for nanomaterials.
Essential Papers
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi, Philip W. Kantoff, Richard Wooster et al. · 2016 · Nature reviews. Cancer · 5.4K citations
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati, Arun Kumar Mahanta, Sunil Kumar et al. · 2018 · Signal Transduction and Targeted Therapy · 2.1K citations
Graphene-Based Antibacterial Paper
Wenbing Hu, Cheng Peng, Weijie Luo et al. · 2010 · ACS Nano · 2.0K citations
Graphene is a monolayer of tightly packed carbon atoms that possesses many interesting properties and has numerous exciting applications. In this work, we report the antibacterial activity of two w...
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar ud Din, Waqar Aman, Izhar Ullah et al. · 2017 · International Journal of Nanomedicine · 1.5K citations
Nanotechnology has recently gained increased attention for its capability to effectively diagnose and treat various tumors. Nanocarriers have been used to circumvent the problems associated with co...
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets
Yusong Tu, Min Lv, Peng Xiu et al. · 2013 · Nature Nanotechnology · 1.5K citations
Controlled Drug Delivery Systems: Current Status and Future Directions
Shivakalyani Adepu, Seeram Ramakrishna · 2021 · Molecules · 1.4K citations
The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointme...
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao, Yunxiang Zhou, Lihong Liu et al. · 2020 · Frontiers in Molecular Biosciences · 1.4K citations
Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-b...
Reading Guide
Foundational Papers
Start with Hu et al. (2010) for graphene oxide antibacterial activity introducing biocompatibility concerns, then Liao et al. (2011) for mammalian cytotoxicity data, and Tu et al. (2013) for mechanistic membrane insights.
Recent Advances
Study Adepu and Ramakrishna (2021) on controlled drug delivery addressing toxicity in systems, and Yao et al. (2020) on nanoparticle drug resistance overcoming with biocompatibility focus.
Core Methods
Core techniques include MTT viability assays (Liao et al., 2011), lipid extraction quantification (Tu et al., 2013), and zone-of-inhibition for antibacterial testing (Hu et al., 2010).
How PapersFlow Helps You Research Graphene Nanomaterials Toxicity Assessment
Discover & Search
Research Agent uses searchPapers and exaSearch to find toxicity-focused papers like 'Cytotoxicity of Graphene Oxide and Graphene in Human Erythrocytes and Skin Fibroblasts' by Liao et al. (2011). citationGraph reveals connections from Hu et al. (2010) antibacterial paper to Tu et al. (2013) membrane studies. findSimilarPapers expands to related cytotoxicity works.
Analyze & Verify
Analysis Agent employs readPaperContent on Liao et al. (2011) to extract dose-response data, then runPythonAnalysis with pandas to plot viability curves from tables. verifyResponse (CoVe) checks claims against Tu et al. (2013) abstracts, with GRADE grading for evidence strength in cytotoxicity mechanisms.
Synthesize & Write
Synthesis Agent detects gaps in long-term in vivo data across Hu et al. (2010) and Liao et al. (2011), flagging contradictions in antibacterial vs. mammalian toxicity. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10 papers, with latexCompile for publication-ready PDFs and exportMermaid for toxicity pathway diagrams.
Use Cases
"Plot cytotoxicity dose-response from graphene oxide papers in human cells"
Research Agent → searchPapers('graphene oxide cytotoxicity erythrocytes') → Analysis Agent → readPaperContent(Liao 2011) → runPythonAnalysis(pandas plot IC50 curves) → matplotlib viability graph output.
"Write LaTeX review on graphene membrane disruption mechanisms"
Synthesis Agent → gap detection(Tu 2013 + Hu 2010) → Writing Agent → latexEditText(intro + mechanisms) → latexSyncCitations(10 papers) → latexCompile → PDF with cited toxicity summary.
"Find code for simulating graphene-cell interactions from toxicity papers"
Research Agent → paperExtractUrls(Tu 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect → molecular dynamics scripts for membrane extraction simulations.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ graphene toxicity) → citationGraph → DeepScan(7-step analysis with GRADE checkpoints on Liao/Tu data) → structured report on mechanisms. Theorizer generates hypotheses on safe thresholds from Hu et al. (2010) antibacterial and Liao et al. (2011) cyto data. DeepScan verifies dose-responses across papers with CoVe.
Frequently Asked Questions
What is Graphene Nanomaterials Toxicity Assessment?
It evaluates cytotoxic effects of graphene oxide on human erythrocytes and fibroblasts (Liao et al., 2011) and bacterial membrane disruption (Tu et al., 2013).
What are key methods in this subtopic?
In vitro assays measure cell viability and reactive oxygen species; membrane lipid extraction assays use E. coli models (Tu et al., 2013); antibacterial zone inhibition tests graphene paper (Hu et al., 2010).
What are the most cited papers?
Liao et al. (2011, 1348 citations) on human cell cytotoxicity; Tu et al. (2013, 1462 citations) on bacterial phospholipid extraction; Hu et al. (2010, 1965 citations) on antibacterial graphene oxide.
What open problems exist?
Long-term in vivo genotoxicity lacks data; standardized protocols for 2D nanomaterials are absent (Bondarenko et al., 2013); safe clinical doses for drug delivery remain undefined.
Research Graphene and Nanomaterials Applications with AI
PapersFlow provides specialized AI tools for Engineering researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Code & Data Discovery
Find datasets, code repositories, and computational tools
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Engineering use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Graphene Nanomaterials Toxicity Assessment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Engineering researchers